Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well plates.
第一作者:
Michaela,Feodoroff
第一单位:
Institute for Molecular Medicine Finland (FIMM), Helsinki Institute for Life Sciences (HiLIFE), University of Helsinki, Helsinki, Finland; Laboratory of Immunovirotherapy, Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Translational Immunology Research Program (TRIMM), University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
作者:
医学主题词
人类(Humans);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);药物发现(Drug Discovery);肿瘤(Neoplasms);胶原(Collagen)
DOI
10.1016/j.slasd.2022.11.003
PMID
36464160
发布时间
2023-03-27
- 浏览0
SLAS discovery
2023年28卷2期
36-41页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



